Product Images Depakote
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Depakote NDC 0074-7325 by Abbvie Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The following structure Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). - depakote tablets spl 01
Figure 1 - depakote tablets spl 02
Figure 2 - depakote tablets spl 03
Figure 3 - depakote tablets spl 04
Figure 4 - depakote tablets spl 05
NDC 0074-6212-13 100 Tablets DEPAKOTE®DIVALPROEX SODIUM DELAYED-RELEASE TABLETS 125 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient. Rx only abbvie - depakote tablets spl 06
This is a description of a medication called Depakote, which comes in a bottle of 100 delayed-release tablets. The active ingredient is valproex sodium. The rest of the text is mostly product information such as the NDC number, the manufacturer's contact information, and instructions to consult a guide before use. The text does not provide any information on the purpose, usage, or potential side effects of the medication.*
NDC 0074-6214-53 500 Tablets DEPAKOTE®DIVALPROEX SODIUM DELAYED-RELEASE TABLETS 250 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient Rx only abbvie - depakote tablets spl 07
This is a prescription drug label for Divalproex Sodium Delayed-Release Tablets with NDC number 0074-7325-13. It contains 100 tablets and has a barcode. The label recommends dispensing the medication guide accompanying the tablets to each patient. The expiration date is not available.*
NDC 0074-6214-13 100 Tablets DEPAKOTE®DIVALPROEX SODIUM DELAYED-RELEASE TABLETS 250 mg Valproic Acid Activity Do not accept if seal over bottle opening is broken or missing. Dispense the accompanying Medication Guide to each patient.Rx only abbvie - depakote tablets spl 08
This is a description of a medication called DEPAKOTE® in the form of delayed-release tablets. The tablets are 250 mg and contain DIVALPROEX SODIUM. The prescription for the medication is only available with a valid Rx.*
NDC 0074-6215-13 100 Tablets DEPAKOTE®DIVALPROEX SODIUM DELAYED-RELEASE TABLETS 500 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient. Rx only abbvie - depakote tablets spl 09
This is a description of a medication called Valproic Acid. It comes in the form of 500 mg tablets, manufactured by AbbVie LTD. The accompanying Medication Guide must be dispersed to the patient. The prescription can only be dispensed with an Rx. The rest of the text is not available due to errors.*
depakote tablets spl 0a
This text provides information regarding a medication called Divalproex Sodium, available in a delayed-release tablet form. The medication has an NDC code of 0074-7327-13 and is packaged with 100 tablets per container. The given text also mentions a 2D barcode and instructions to dispense the medication with the accompanying Medication Guide to each patient.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.